BASTIDE (EPA:BLC) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
BASTIDE

BRIEF

published on 11/14/2024 at 18:05, 6 days 19 hours ago

Bastide Group: Strong performance in the first quarter of 2024-2025

Organic Growth International Health Benefits Turnover Financial Objectives
PRESS RELEASE

published on 11/14/2024 at 18:00, 6 days 19 hours ago

Highly dynamic organic growth in Q1 2024-25 at 9.0% : 10.9% growth in home healthcare services and rebound in the homecare business, up 6.0% / Disposal of Swiss commercial business finalized and 2024-2025 targets confirmed
Groupe Bastide reports solid organic growth of 9.0% in the first-quarter 2024-2025, with revenue reaching €133.8 million. Key focus on home healthcare services, international expansion, and strategic financial objectives

Revenue Organic Growth Financial Objectives Groupe Bastide Home Healthcare Services
BRIEF

published on 11/06/2024 at 18:20, 14 days 19 hours ago

Bastide Le Confort Médical: Information on Shares and Voting Rights in October 2024

Voting Rights Actions AMF BASTIDE MEDICAL COMFORT October 2024
BRIEF

published on 11/04/2024 at 18:05, 16 days 19 hours ago

Bastide Financial Calendar 2024-2025

Financial Calendar Annual Results Turnover Bastide Group 2024-2025
PRESS RELEASE

published on 11/04/2024 at 18:00, 16 days 19 hours ago

2024-2025 financial calendar
Groupe Bastide Le Confort Médical to report first-quarter revenue on Nov 14, 2024. Leading provider of home healthcare services since 1977, listed on Euronext Paris

Euronext Paris Revenue Medical Devices Groupe Bastide Home Healthcare Services
BRIEF

published on 10/31/2024 at 22:50, 20 days 14 hours ago

Provision of the 2023-2024 annual financial report by the Bastide Group

Investors Financial Report Turnover Bastide Group 2024-2025
BRIEF

published on 10/23/2024 at 18:50, 28 days 18 hours ago

Bastide Reports Steady Growth and Improved Margins for 2023-2024

Revenue Growth Debt Reduction Operating Margin Strategic Management Home Healthcare
PRESS RELEASE

published on 10/23/2024 at 18:45, 28 days 18 hours ago

2023-2024 annual results : Solid growth in revenue and recurring operating margin of 8.5%, exceeding the target / improved profitability and a focus on reducing debt in 2024-25
Groupe Bastide announces 2023-2024 financial year earnings, with revenue of €529.8 million and organic growth of 7.4%. Recurring operating margin exceeds target. Debt reduction and leverage improvement are key goals for the future

Revenue Financial Year Earnings Debt Reduction Groupe Bastide
BRIEF

published on 10/23/2024 at 18:35, 28 days 19 hours ago

Annual results 2023-2024: Solid performance of Bastide with prudent financial management

Financial Results Debt Reduction Turnover Bastide Home Health
BRIEF

published on 10/04/2024 at 18:20, 1 month 16 days ago

Number of shares and voting rights of Bastide as of September 30, 2024

Shareholders Voting Rights Actions AMF Bastide

Accesswire

Published on 11/21/2024 at 13:00, 38 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 38 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 38 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 22 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 2 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 23 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 31 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 37 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 40 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 18 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE